跳至主要内容
临床试验/NCT00226265
NCT00226265已完成不适用

The Short Form-36: Pre-vs. Post-Surgical Administration in Cardiac Surgery Patients

Weill Medical College of Cornell University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 1999年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
1

研究概览

简要总结

The purpose of this study is to determine whether the SF-36 can be administered reliably to cardiac surgery patients (two to three days) post-surgery, with the patient answering the questions of this survey from a pre-surgical perspective.

详细描述

The purpose of this study, is to determine whether the SF-36 can be administered reliably to cardiac surgery patients (two to three days) post-surgery, with the patient answering the questions of this survey from a pre-surgical perspective.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Cardiac surgery patients who are between the ages of 18 and 100
  • Are English speaking
  • Able to give consent
  • Undergoing cardiac surgery including (but not limited to):
  • Aortic valve replacement (AVR)
  • Mitral valve replacement (MVR)
  • Tricuspid valve replacement (TVR)
  • Coronary artery bypass graft (CABG).

排除标准

  • Non-cardiac surgery patients

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mary E. Charlson, MD

Principal Investigator

Weill Medical College of Cornell University

研究点 (1)

Loading locations...

相似试验